🔗 Share this article

Grammy-winning R&B singer D’Angelo passed away on October 14 at 51 years old after a personal fight with pancreatic malignancy.

“The shining star of our household has faded away for us in the present world,” his family stated. “After a lengthy and courageous struggle with the disease, we are heartbroken to announce that D’Angelo, known to his followers around the globe as D’Angelo, has been taken from us.”

D’Angelo left an indelible mark on the music industry with his innovative modern soul style and partnerships with renowned musicians.

He released his first record, “Brown Sugar,” in 1995 to immediate acclaim. The record reached No. 4 on the R&B charts, went platinum soon after, and received multiple award nominations.

However, it was his second album, “Voodoo,” in 2000 that boosted his artistic journey into the limelight. The record premiered at No. 1 on both the R&B charts and the Billboard 200. He won two Grammy Awards: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a icon, albeit a hesitant one, in the cultural zeitgeist. The personal depiction featured the singer, famously bare to his midsection, performing straight into the camera.

D’Angelo retreated from the spotlight after releasing Voodoo and openly battled with drugs and alcohol. In 2005, he was involved in a serious vehicle accident that left him in grave health.

Over ten years later, his third and final album, “Black Messiah” (2014), reaffirmed his lasting popularity with another No. 1 debut on the R&B chart and a Grammy for Best R&B Album.

Again, in his own mysterious fashion, D’Angelo had limited public outings in the subsequent period.

The musician was announced as a top act for the 2025 Roots Picnic festival, but his performance was called off, due to an “unexpected health issue.”

Even though information is limited about D’Angelo’s health in the weeks leading up to his death, he had apparently been hospitalized for months and in palliative care for two weeks.

D’Angelo’s demise is a stark reminder of the devastating effects of pancreatic malignancy, one of the most deadly and hardest to prevent forms of the illness, on a brilliant talent whose life was ended too soon.

“We are grieved that he can only provide cherished moments with his loved ones, but we are forever thankful for the heritage of deeply emotional songs he has left us,” his family expressed.

Pancreatic Malignancy: Deadly and Rarely Preventable

Pancreatic malignancy affects the digestive organ, a small organ that produces insulin and plays an essential role in breaking down food, among other functions. The size and location of the organ in the body make it more difficult to detect cancer.

Although this cancer accounts for only approximately three percent of malignancy cases each year in the U.S., it is causes seven percent of malignancy fatalities.

Almost seventy thousand individuals will be diagnosed with this condition and about 52,000 will die of the illness in the year 2025.

“This malignancy is one of the most lethal diseases, with an aggressive tumor and poor prognosis. We have few and poor treatment options, and a narrow opportunity to make a significant difference on the well-being of patients,” said a medical oncologist.

Since this disease seldom produces early symptoms, it’s frequently identified only after the condition is late-stage. Although a individual has symptoms they are usually vague and may be confused with a several common illnesses.

“Currently, there is no good way to detect pancreatic cancer in the early stages, apart from listening to your body and consulting your doctor if there are new or unusual signs,” explained a health expert.

Common symptoms of this disease encompass:

• abdominal or lower back pain
• reduced body mass
• jaundice
• reduced hunger
• dark urine
• pale or fatty bowel movements
• loose stools
• excessive hunger or thirst
• nausea

At age 51, D’Angelo’s demise is an outlier, as this malignancy is most common in individuals in the 65 to 75 age bracket. However, many cancers, including pancreatic cancer, have become more common in younger people.

“This disease diagnosed prior to fifty is deemed uncommon, yet alarmingly, clinicians are noticing a rising count of younger patients suffering from this disease,” commented a specialist.

Family History Affects Disease Probability

In the absence of reliable screening tools for pancreatic cancer, experts stressed the significance of knowing your family’s cancer history. Certain risk factors, such as smoking and excess weight also have an influence in the onset of pancreatic cancer.

Black individuals have the highest incidence of pancreatic cancer in the U.S. and are more prone to be diagnosed with inoperable cancer.

“The initial action toward reducing one’s risk of pancreatic cancer is assessing individual susceptibility. People should examine their genetic background, genetic background, and health issues, such as blood sugar disease, long-term pancreas inflammation, or obesity that may raise their susceptibility,” said a specialist.

Hereditary elements are linked to as much as ten percent of all pancreatic cancer cases. If someone in your household has had this disease, you may want to consider genetic testing.

“For individuals with a family history of this condition or those carrying elevated risk DNA changes, screening may involve advanced imaging such as magnetic resonance imaging (MRI) or internal ultrasound to find initial alterations in the organ,” he explained.

For those looking to reduce their risk, lifestyle changes may make a difference. The best step you can take to reduce your susceptibility of this disease is to quit smoking, and if you are a non-smoker, stay away altogether.

Heavy alcohol consumption is associated with pancreatitis, a contributing element for this malignancy, so limiting or abstaining from drinks may assist reduce your risk.

Controlling your body mass or losing weight may also aid decrease your susceptibility. Individuals with obesity are 20% more likely to get this disease. Pancreatic cancer also is more frequent in those with blood sugar issues, and weight loss can also lower the risk of type 2 diabetes.

In spite of this disease’s poor prognosis, there is reason for optimism.

“We are making progress with treatments and more recent mixed drug treatments. There are developing precision medicines that are already making an impact,” said a expert.

For many people, however, awareness about this rare but {dev